Hacker News new | past | comments | ask | show | jobs | submit login

This struck me as well. The only thing that comes to mind is the way to administer minocycline. But it's obvious that if the treatment works well, other researchers will find other ways to administer this drug, so I don't see a point. They probably follow a standard procedure to recoup the cost of research, but since they choose a generic drug, I wonder if there is a way to monetize it at all.

Registration is open for Startup School 2019. Classes start July 22nd.

Guidelines | FAQ | Support | API | Security | Lists | Bookmarklet | Legal | Apply to YC | Contact